Navigation Links
U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
Date:10/18/2007

Onco-genomic guided trial design may increase probability of tumor response

and accelerates drug development

SEATTLE, Oct. 18 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) and Systems Medicine, LLC (SM), a wholly-owned subsidiary of CTI, today announced the enrollment of the first patient to its complete phase Ib trial of brostallicin used in combination with either bevacizumab or irinotecan, for patients with advanced solid tumors. Combining brostallicin with either bevacizumab or irinotecan is based on existing preclinical data that strongly supports taking these combinations into the clinic. A third treatment arm, which will include brostallicin in combination with an anticancer agent to be identified, will be added to the study. The agent will be identified from ongoing pharmacogenomic investigations using genomic-based search strategies to identify agents that are synergistic with brostallicin.

The trial, being conducted at multiple U.S. Oncology sites, is unique because of the novel "complete" phase I trial design and that genomic-driven discovery is being used to identify at least one of the agents for use with brostallicin. The study design combines a new drug with existing therapies, selected based on genomic profiling, to increase the probability of seeing tumor responses in phase I and may enhance the overall success of the development program. The complete phase I trial design, which was first reported at the 2007 Annual Meeting of the American Society for Clinical Oncology (ASCO), allows several combination phase 1 trials be conducted simultaneously.

"Most new drug approvals in development are in combination with existing regimens by phase III. By utilizing the complete phase I design, it is possible to rapidly explore several genomicly-guided combinations that could speed the development process and potentially bring benefit to more patients," said Daniel D. Von Hoff, M.D.,
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Radiation Overdose at the Beatson Oncology Centre
2. Videoconferencing, an impetus to Pediatric Oncology
3. Oncology Drug Pemnat Launched By NATCO
4. United Biotech Launches New Oncology Division
5. Bengal Teenager to Participate in World Oncology Camp
6. CMPMedica Adds Oncology Search Engine to SearchMedica.com
7. Bird Flu: Orissa Initiates Protective Measures
8. Biota Initiates Drug Testing War against Common Cold
9. Russia Initiates Mass Vaccination Of Poultry To Restrict Bird Flu
10. Government Initiates A Program To Curb HIV
11. Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...w Sanctuary, a Dedicated Wellness Director and a N...2009 , , SANTA MONICA, Calif., Dec. 2 /PRN...otelcasadelmar.com/ ) offers guests the unique opp...raveling, with its new "Wellness Your Way" program... of programs focusing on mental and physical welln...
(Date:12/2/2008)...rstCall/ -- VirtualScopics, Inc.,(Nasdaq: VSCP ...clinical,trials, today announced that its backlog...million at the same time a year ago, a greater tha... the amount remaining to be,recognized from activ...es,included within the backlog ranges from 2 mont...
(Date:12/2/2008)... 2 The nationally recog...sident-elect Obama urging him to fulfill his campa...lable by allowing any American to join Medicare, r...oposal pushed by health insurance companies to req... policies "amounts only to a government-funded cus...
(Date:12/2/2008)...y Cite Prevention, Shedding, or Sharing Costs as K...swire/ -- A New Center for State and Local Governm...ncing retiree health care plans and their need to ...the American States examines how state administra...e benefits to central human resources (HR) goals; ...
Breaking Medicine News(10 mins):Health News:Photos: Hotel Casa del Mar Offers New 'Wellness Your Way' Program 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 3Health News:Consumer Watchdog to Obama: Open Medicare to All Americans 2Health News:Consumer Watchdog to Obama: Open Medicare to All Americans 3Health News:States View Limits on Retiree Health Benefits 2
...ndia is probably much higher than official data sh...am says.// India, which has 5.1 million people wit...cord, announced earlier in 2005 that new infection...in 2004, down from 520,000 in 2003. International...
...can improve exercise capacity and functional abili...n, a serious disease involving high pressure in th...suggests.// According to a report by Reuters, the ...and Journal of Medicine, are based on a study of 2...
...Sciences (AIIMS) proposes to construct a new terti... of the Government to provide land for construct...modern facilities. The Central Arid Zone Research...dealing with arid regions has agreed to provide 10...
...emists at Harvard University, who say that these p...igger could hold the key to oncogenesis,// the pro...ises when an oncoprotien, a protein known to cause... the development of cancer, 'We present the hypoth...
Other Medicine News:
(Date:12/2/2008)...erapeutics, Inc., a,privately held biopharmaceuti...se 3 trials evaluating its lead investigational pr...ts. HZT-501, a novel, proprietary fixed-dose,comb...e, demonstrated a,statistically significant reduc...mmatory drug (NSAID)-induced upper gastrointestina...
(Date:12/1/2008)...announced that an oral,presentation of prelimina...,trial of TG101348 in myeloproliferative disease p...ociety of Hematology (ASH) Meeting. , , Det...tle: A Phase I Study of TG101348, an ...Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)... , ROCHESTER, Minn., Dec. 1 /PRNewswire-USNews...e of the drug therapy etanercept ineffective in tr...of the liver caused by excessive consumption of al...he December issue of Gastroenterology ( http://w...Additional audio and video resources, including ex...
(Date:12/1/2008)...al Incorporated (Nasdaq: VICL ) announced today ...om Merck & Co., Inc. based on Merck,s planned ...tigational plasmid DNA (pDNA) cancer vaccine. The ...ivery technology and encodes human telomerase reve... separate license agreement. , , "The bread...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Robotic Surgeons From Around the World Attend One of a Kind Conference by Global Robotics Institute at Florida Hospital 14446 1Robotic Surgeons From Around the World Attend One of a Kind Conference by Global Robotics Institute at Florida Hospital 14446 2Blood Thinner Contaminant Traced to Chinese Plant 14444 1Blood Thinner Contaminant Traced to Chinese Plant 14444 2Blood Thinner Contaminant Traced to Chinese Plant 14444 3Penn researchers identify first sex chromosome gene involved in meiosis and male infertility 14441 1Penn researchers identify first sex chromosome gene involved in meiosis and male infertility 14441 2White Men With Chest Pains Treated Fastest in ERs 14437 1White Men With Chest Pains Treated Fastest in ERs 14437 2White Men With Chest Pains Treated Fastest in ERs 14437 3
...SIGA Technologies, Inc.,(NASDAQ: SIGA) announced t...guinea pig trial of its lead Lassa fever virus dru...ty Level 4 conditions at,the U.S. Army Medical Res...by Dr. Kathleen Cashman under the supervision of D...hemorrhagic fever,viruses at USAMRIID for over 12 ...
... data on leading,drug-eluting stent portfolio, NAT... Boston,Scientific Corporation today announced the...announcements at the annual Paris,Course on Revasc...,to 25 in Barcelona, Spain. , "We will be announci...d registries, adding to the knowledge base for tre...
Other Medicine Technology:SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 2SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 3SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 4Boston Scientific Announces Schedule for EuroPcr 2007 2Boston Scientific Announces Schedule for EuroPcr 2007 3Boston Scientific Announces Schedule for EuroPcr 2007 4Boston Scientific Announces Schedule for EuroPcr 2007 5
...se ECG Systems offer clinical features to meet any...e functionality for paperless storage. Flexible, a...PCE Exercise ECG software turns any computer into ...y to connect with leading EMR systems, the family ...
The Quinton Q-Stress Cardiac Stress Monitor combines Quinton algorithms, unique baseline wander and muscle artifact filters, and 8000 samples per second to provide the highest ECG fidelity in the ind
The CASE 8000 is one of the first, true point-of-care clinical information systems for the exercise environment. By combining the accuracy of our premiere exercise ECG system with the information acc
...cise stress system, the Quest, combines innovative...ic capabilities. Combined with a 15" color monitor...e screen to program or select specific functions. ..., highlighting the step usually taken next. No mor...
Medicine Products: